nickel monoxide has been researched along with Pneumonia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, KJ; Chen, JK; Chen, KY; Chuang, HC; Chuang, KJ; Ho, KF; Hsiao, TC; Hua, HE; Lee, CH; Lee, KY; Liao, WN; Pan, CH; Shen, YL | 1 |
| Cho, WS; Jeong, J; Kim, J; Seok, SH | 1 |
| Horie, M; Izumi, H; Kawaguchi, K; Kawai, K; Kitajima, S; Kubo, M; Kuroda, E; Lee, BW; Morimoto, Y; Myojo, T; Okada, T; Oyabu, T; Sasaki, T; Shimada, M; Tomonaga, T; Yamamoto, K; Yatera, K; Yoshiura, Y | 1 |
| Cao, Z; Fang, Y; He, M; Lu, Y; Ma, Q; Pi, H; Qian, F; Yu, Z; Zhou, Z | 1 |
| Ajimi, S; Hashizume, N; Imatanaka, N; Kobayashi, T; Nakai, M; Oshima, Y; Tsubokura, Y | 1 |
| Daly, P; Donaldson, K; Drost, E; Duffin, R; Lu, S; Macnee, W; Murphy, F; Poland, C; Stone, V | 1 |
| Bradley, M; Cho, WS; Donaldson, K; Duffin, R; Howie, SE; MacNee, W; Megson, IL; Poland, CA | 1 |
| Endoh, S; Fujita, K; Hirohashi, M; Kadoya, C; Kobayashi, N; Morimoto, Y; Murakami, M; Myojo, T; Nagatomo, H; Nakanishi, J; Nishi, K; Ogami, A; Oyabu, T; Tanaka, I; Todoroki, M; Uchida, K; Yamamoto, K; Yamamoto, M; Yamasaki, S | 1 |
| Hashiba, M; Hirohashi, M; Kambara, T; Kuroda, E; Lee, BW; Mizuguchi, Y; Morimoto, Y; Myojo, T; Ogami, A; Oyabu, T; Tanaka, I | 1 |
| Endoh, S; Hashiba, M; Kadoya, C; Lee, BW; Mizuguchi, Y; Morimoto, Y; Myojo, T; Nakanishi, J; Nishi, K; Ogami, A; Oyabu, T; Shimada, M; Tanaka, I; Todoroki, M; Uchida, K; Yamamoto, M | 1 |
10 other study(ies) available for nickel monoxide and Pneumonia
| Article | Year |
|---|---|
Investigation into the pulmonary inflammopathology of exposure to nickel oxide nanoparticles in mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Bronchoalveolar Lavage Fluid; Deoxyguanosine; Female; Lung Injury; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Nickel; Pneumonia; Proteome | 2018 |
Indium oxide (In2O3) nanoparticles induce progressive lung injury distinct from lung injuries by copper oxide (CuO) and nickel oxide (NiO) nanoparticles.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cells, Cultured; Copper; Cytokines; Female; Indium; Ki-67 Antigen; Lung Injury; Macrophages, Alveolar; Metal Nanoparticles; Nickel; Phospholipids; Pneumonia; Rats, Wistar; Reactive Oxygen Species | 2016 |
Comparison of pulmonary inflammatory responses following intratracheal instillation and inhalation of nanoparticles.
Topics: Administration, Inhalation; Animals; Bronchoalveolar Lavage Fluid; Cytokines; Instillation, Drug; Lung; Male; Nanoparticles; Neutrophils; Nickel; Pneumonia; Rats; Rats, Wistar; Titanium | 2016 |
Exposure to nickel oxide nanoparticles induces pulmonary inflammation through NLRP3 inflammasome activation in rats.
Topics: Animals; Carrier Proteins; Caspase 1; Caspase Inhibitors; Cell Line; Cytokines; Environmental Pollutants; Inflammasomes; Interleukin-1beta; Macrophages; Male; Metal Nanoparticles; Mice; Nickel; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Small Interfering | 2016 |
Effects of pentobarbital, isoflurane, or medetomidine-midazolam-butorphanol anesthesia on bronchoalveolar lavage fluid and blood chemistry in rats.
Topics: Administration, Inhalation; Analgesics, Opioid; Anesthesia; Anesthetics, Inhalation; Animals; Biomarkers; Bronchoalveolar Lavage Fluid; Butorphanol; Disease Models, Animal; Hypnotics and Sedatives; Injections, Intraperitoneal; Isoflurane; Lung; Male; Medetomidine; Midazolam; Nickel; Pentobarbital; Pneumonia; Rats, Inbred F344; Risk Assessment | 2016 |
Efficacy of simple short-term in vitro assays for predicting the potential of metal oxide nanoparticles to cause pulmonary inflammation.
Topics: Aluminum Oxide; Cell Line; Erythrocytes; Hemolysis; Humans; Metal Nanoparticles; Nickel; Oxides; Pneumonia | 2009 |
Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cerium; Copper; Cytokines; Female; Hazardous Substances; Inhalation Exposure; Lung; Metal Nanoparticles; Nickel; Oxides; Pneumonia; Rats; Rats, Wistar; Silicon Dioxide; Soot; Titanium; Toxicity Tests; Zinc Oxide | 2010 |
Expression of inflammation-related cytokines following intratracheal instillation of nickel oxide nanoparticles.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Instillation, Drug; Intubation, Intratracheal; Lung; Macrophages, Alveolar; Male; Microscopy, Electron, Transmission; Nanoparticles; Nickel; Particle Size; Pneumonia; Rats; Rats, Wistar | 2010 |
Pulmonary toxicity following an intratracheal instillation of nickel oxide nanoparticle agglomerates.
Topics: Animals; Bronchoalveolar Lavage Fluid; Chemokines; Chemokines, CXC; Leukocyte Count; Male; Metal Nanoparticles; Neutrophils; Nickel; Pneumonia; Rats; Rats, Wistar | 2011 |
Comparison of dose-response relations between 4-week inhalation and intratracheal instillation of NiO nanoparticles using polimorphonuclear neutrophils in bronchoalveolar lavage fluid as a biomarker of pulmonary inflammation.
Topics: Animals; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Inhalation Exposure; Instillation, Drug; Leukocyte Count; Macrophages, Alveolar; Male; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Neutrophils; Nickel; Particle Size; Pneumonia; Rats; Rats, Wistar; Surface Properties; Toxicity Tests, Subacute; Trachea | 2013 |